Patents-Review.com
🔗 Permalink
Assignee profile:

CHRONTECH PHARMA AB

City:

Huddinge

Country:

Sweden

Published Applications:

17

Last publication date:

2014-09-25

Patent Grants:

13

Last grant date:

2016-10-04

Top Inventors for applications by CHRONTECH PHARMA AB

These are the the leading inventors for applications assigned to CHRONTECH PHARMA AB:

Recent patent applications by CHRONTECH PHARMA AB

CHRONTECH PHARMA AB based in Huddinge, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-09-25
US20140286985A1
Chemistry; metallurgy

SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES

 #2 | 2014-05-01 ✅ Patent 9,457,183 granted on 2016-10-04
US20140121587A1
Human necessities

Injection needle and device

 #3 | 2013-08-08
US20130202554A1
Human necessities

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

 #4 | 2013-02-14 ✅ Patent 8,658,179 granted on 2014-02-25
US20130041131A1
Human necessities

Glycosylated specificity exchangers

 #5 | 2013-01-10
US20130012865A1
Human necessities

CODON-OPTIMZED HEPATITIS B VIRUS CORE ANTIGEN (HBCAG)

 #6 | 2013-01-10 ✅ Patent 9,193,778 granted on 2015-11-24
US20130011375A1
Chemistry; metallurgy

T cell receptors specific for immunodominant CTL epitopes of HCV

 #7 | 2012-08-16
US20120208870A1
Chemistry; metallurgy

HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE

 #8 | 2012-02-16 ✅ Patent 8,445,663 granted on 2013-05-21
US20120039842A1
Chemistry; metallurgy

Compositions and methods that enhance an immune response

 #9 | 2012-01-12 ✅ Patent 8,883,169 granted on 2014-11-11
US20120010394A1
Chemistry; metallurgy

Immunogen platform

 #10 | 2011-06-23 ✅ Patent 8,258,275 granted on 2012-09-04
US20110150922A1
Human necessities

Immunogen platform

 #11 | 2011-04-07 ✅ Patent 8,158,602 granted on 2012-04-17
US20110082287A1
Chemistry; metallurgy

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #12 | 2011-04-07 ✅ Patent 8,163,712 granted on 2012-04-24
US20110081381A1
Chemistry; metallurgy

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #13 | 2011-03-17 ✅ Patent 8,163,547 granted on 2012-04-24
US20110065174A1
Chemistry; metallurgy

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #14 | 2010-07-22 ✅ Patent 8,303,956 granted on 2012-11-06
US20100183635A1
Human necessities

Glycosylated specificity exchangers

 #15 | 2010-04-29 ✅ Patent 7,943,149 granted on 2011-05-17
US20100104592A1
Chemistry; metallurgy

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #16 | 2009-08-27 ✅ Patent 7,968,697 granted on 2011-06-28
US20090215869A1
Human necessities

Hepatitis C virus non-structural NS3/4A fusion gene

 #17 | 2009-03-19 ✅ Patent 8,071,561 granted on 2011-12-06
US20090074803A1
Chemistry; metallurgy

Immunogen platform

Also check out ChronTech Pharma AB's (Huddinge, Sweden) applicant profile with 2 patent applications submitted.

AssigneeID:

3325 ⎘